Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.

Xiaoshuang Kong,Xudong Zhang,Mengjie Ding,Xiaoyan Feng,Meng Dong,Lei Zhang,Xiaorui Fu, Ling Li, Xin Li,Zhenchang Sun,Jiaqin Yan,Xinhua Wang,Xiaolong Wu,Qingjiang Chen,Mingzhi Zhang,Linan Zhu

Cancer medicine（2023）

Cited 1|Views49
No score
Abstract
The decitabine-RDHAP regimen is effective and well tolerated, and is a promising salvage regimen for R/R-DLBCL.
More
Translated text
Key words
chemotherapy,decitabine,diffuse large B-cell lymphoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined